Your browser doesn't support javascript.
loading
Interleukin-1RA Mitigates SARS-CoV-2-Induced Inflammatory Lung Vascular Leakage and Mortality in Humanized K18-hACE-2 Mice.
Xiong, Shiqin; Zhang, Lianghui; Richner, Justin M; Class, Jake; Rehman, Jalees; Malik, Asrar B.
Afiliação
  • Xiong S; Department of Pharmacology and Regenerative Medicine and the Center for Lung and Vascular Biology (S.X., L.Z., J.R., A.B.M.), University of Illinois College of Medicine at Chicago.
  • Zhang L; Now with Department of Cardiometabolic Diseases, Merck Research Laboratories, South San Francisco, CA (S.X.).
  • Richner JM; Department of Pharmacology and Regenerative Medicine and the Center for Lung and Vascular Biology (S.X., L.Z., J.R., A.B.M.), University of Illinois College of Medicine at Chicago.
  • Class J; Department of Microbiology and Immunology (J.M.R., J.C.), University of Illinois College of Medicine at Chicago.
  • Rehman J; Division of Cardiology, Department of Medicine (J.R.), University of Illinois College of Medicine at Chicago.
  • Malik AB; Department of Microbiology and Immunology (J.M.R., J.C.), University of Illinois College of Medicine at Chicago.
Arterioscler Thromb Vasc Biol ; 41(11): 2773-2785, 2021 11.
Article em En | MEDLINE | ID: mdl-34496633

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptores de Interleucina-1 / Proteína Antagonista do Receptor de Interleucina 1 / COVID-19 / Tratamento Farmacológico da COVID-19 Limite: Animals Idioma: En Revista: Arterioscler Thromb Vasc Biol Assunto da revista: ANGIOLOGIA Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptores de Interleucina-1 / Proteína Antagonista do Receptor de Interleucina 1 / COVID-19 / Tratamento Farmacológico da COVID-19 Limite: Animals Idioma: En Revista: Arterioscler Thromb Vasc Biol Assunto da revista: ANGIOLOGIA Ano de publicação: 2021 Tipo de documento: Article